LifeTech Scientific Corp
HKEX:1302

Watchlist Manager
LifeTech Scientific Corp Logo
LifeTech Scientific Corp
HKEX:1302
Watchlist
Price: 1.43 HKD 3.62% Market Closed
Market Cap: 6.6B HKD

LifeTech Scientific Corp
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LifeTech Scientific Corp
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
LifeTech Scientific Corp
HKEX:1302
Tax Provision
-ÂĄ30.5m
CAGR 3-Years
15%
CAGR 5-Years
7%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Tax Provision
-ÂĄ74.2m
CAGR 3-Years
-63%
CAGR 5-Years
-63%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Tax Provision
-ÂĄ301.6m
CAGR 3-Years
-19%
CAGR 5-Years
-23%
CAGR 10-Years
-20%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Tax Provision
-ÂĄ1.4B
CAGR 3-Years
-11%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Tax Provision
-ÂĄ212m
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
-10%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Tax Provision
-ÂĄ164.5m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

LifeTech Scientific Corp
Glance View

Market Cap
6.6B HKD
Industry
Health Care

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

Intrinsic Value
1.94 HKD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is LifeTech Scientific Corp's Tax Provision?
Tax Provision
-30.5m CNY

Based on the financial report for Dec 31, 2024, LifeTech Scientific Corp's Tax Provision amounts to -30.5m CNY.

What is LifeTech Scientific Corp's Tax Provision growth rate?
Tax Provision CAGR 5Y
7%

Over the last year, the Tax Provision growth was 55%. The average annual Tax Provision growth rates for LifeTech Scientific Corp have been 15% over the past three years , 7% over the past five years .

Back to Top